These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Glucocorticoid pathways in chronic obstructive pulmonary disease therapy. Adcock IM; Ito K Proc Am Thorac Soc; 2005; 2(4):313-9; discussion 340-1. PubMed ID: 16267355 [TBL] [Abstract][Full Text] [Related]
4. Pharmacological strategies for improving the efficacy and therapeutic ratio of glucocorticoids in inflammatory lung diseases. Newton R; Leigh R; Giembycz MA Pharmacol Ther; 2010 Feb; 125(2):286-327. PubMed ID: 19932713 [TBL] [Abstract][Full Text] [Related]
8. Heterogeneity in mechanisms influencing glucocorticoid sensitivity: the need for a systems biology approach to treatment of glucocorticoid-resistant inflammation. Keenan CR; Radojicic D; Li M; Radwan A; Stewart AG Pharmacol Ther; 2015 Jun; 150():81-93. PubMed ID: 25596317 [TBL] [Abstract][Full Text] [Related]
10. Glucocorticoids: new mechanisms and future agents. Adcock IM Curr Allergy Asthma Rep; 2003 May; 3(3):249-57. PubMed ID: 12662475 [TBL] [Abstract][Full Text] [Related]
11. Steroidal nondepolarizing muscle relaxants do not simulate the effects of glucocorticoids on glucocorticoid receptor-mediated transcription in cultured skeletal muscle cells. Yasukawa T; Kaneki M; Yasuhara S; Lee SL; Martyn JA Anesthesiology; 2004 Jun; 100(6):1615-9. PubMed ID: 15166588 [No Abstract] [Full Text] [Related]
12. Chronic obstructive pulmonary disease: an update on nuclear signaling related to inflammation and anti-inflammatory treatment. Mroz RM; Holownia A; Chyczewska E; Braszko JJ J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():35-42. PubMed ID: 19218631 [TBL] [Abstract][Full Text] [Related]
13. [Mechanisms and strategies of glucocorticoid insensitivity in the treatment of chronic obstructive pulmonary disease]. Xin XF Zhonghua Jie He He Hu Xi Za Zhi; 2011 Nov; 34(11):852-4. PubMed ID: 22333475 [No Abstract] [Full Text] [Related]
14. Differentiation of in vitro transcriptional repression and activation profiles of selective glucocorticoid modulators. Elmore SW; Pratt JK; Coghlan MJ; Mao Y; Green BE; Anderson DD; Stashko MA; Lin CW; Falls D; Nakane M; Miller L; Tyree CM; Miner JN; Lane B Bioorg Med Chem Lett; 2004 Apr; 14(7):1721-7. PubMed ID: 15026058 [TBL] [Abstract][Full Text] [Related]
15. Molecular mechanisms of corticosteroid actions. Adcock IM; Ito K Monaldi Arch Chest Dis; 2000 Jun; 55(3):256-66. PubMed ID: 10948677 [TBL] [Abstract][Full Text] [Related]
16. Glucocorticoids induce mitochondrial gene transcription in HepG2 cells: role of the mitochondrial glucocorticoid receptor. Psarra AM; Sekeris CE Biochim Biophys Acta; 2011 Oct; 1813(10):1814-21. PubMed ID: 21664385 [TBL] [Abstract][Full Text] [Related]
17. Factors involved in the control of fibroblast proliferation by glucocorticoids: a review. Durant S; Duval D; Homo-Delarche F Endocr Rev; 1986 Aug; 7(3):254-69. PubMed ID: 2427332 [No Abstract] [Full Text] [Related]
18. [Mechanisms of action of glucocorticoids. Application to the treatment of respiratory inflammation]. Mullol J; Pujols L; Picado C Arch Bronconeumol; 1996 Dec; 32(10):527-34. PubMed ID: 9019313 [No Abstract] [Full Text] [Related]